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Abstract
The present study examined the immunological response of antigen presenting cells (APC) to genotype-I isolates
of porcine reproductive and respiratory syndrome virus (PRRSV) infection by analysing the cytokine profile induced
and evaluating the changes taking place upon infection on immunologically relevant cell markers (MHCI, MHCII,
CD80/86, CD14, CD16, CD163, CD172a, SWC9). Several types of APC were infected with 39 PRRSV isolates. The
results show that different isolates were able to induce different patterns of IL-10 and TNF-a. The four possible
phenotypes based on the ability to induce IL-10 and/or TNF-a were observed, although different cell types
seemed to have different capabilities. In addition, isolates inducing different cytokine-release profiles on APC could
induce different expression of cell markers.
Introduction
Porcine reproductive and respiratory syndrome virus
(PRRSV) is one of the major pathogens affecting the
swine industry worldwide. Control of the infection has
proven to be difficult because of the limited knowledge
on the ways by which the virus is transmitted between
herds and also because of the lack of fully and univer-
sally protective vaccines. One of the main obstacles for
the development of efficacious vaccines against PRRSV
is the very partial understanding of PRRS immuno-
pathogenesis. A few years ago, several papers compre-
hensively described the adaptive immune response to
PRRS and showed that after infection or vaccination
with either European or American PRRSV strains, pigs
develop a rapid humoral response devoid of neutralising
antibodies (NA). For some not yet fully elucidated rea-
sons, NA develop much later in the course of infection
[1]. Cell-mediated immunity, measured as virus-specific
interferon-gamma (IFN-g) secreting cells (SC), has an
erratic behaviour for several weeks after the onset of
infection [2-4] showing afterwards a trend to increase
and reach a steady state. To explain such a unique pic-
ture of the adaptive immune response against viral
infection seems to rely mostly but not only, on the early
events of the innate immune response [5,6].
E a r l ys t u d i e s[ 7 ]s h o w e dt h a tP R R S Vw a su n a b l et o
induce significant IFN-a r e s p o n s e si nv i v oo ri nv i t r o .
Also, infection of porcine macrophages with PRRSV
impaired or abolished the IFN-a responses against trans-
missible gastroenteritis virus that is known to be a potent
IFN-a inducer. Later on, other authors [8] showed that
different North American PRRSV (genotype-II) isolates
differed in their sensitivity to IFN-a and in their capabil-
ities for inducing this cytokine. These authors suggested
that the inhibition of IFN-a responses by PRRSV may be
mediated by post-transcriptional mechanisms of regula-
tion. IFN-a is not the only cytokine that seems to be
affected by PRRSV infection. Several papers showed that
interleukin-10 (IL-10) may play a role in the regulation of
the immune response in PRRSV infection both in vitro
and ex vivo [1-3,9,10]. Nevertheless, it has also been
reported that different strains may induce different IL-10
responses in PBMC [3] and, therefore, different outcomes
of the infection and the resulting immune response could
be expected after infection with different strains. In addi-
tion, American-type PRRSV isolates seem to be able to
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immune response of antigen presenting cells (APC), in
particular major histocompatibility complex (MHC)
expression [10,11] and CD80/86 [12].
Taking into account those previous reports, it has
become evident that IFN-a and IL-10 are clear targets
for studying the regulation of the immune response
against PRRSV. However, the available evidences suggest
that different strains may probably produce different
cytokine release patterns [13].
In the present study, a large collection of PRRSV
strains was chosen to study the in vitro effects of
PRRSV in different types of APC, with particular
emphasis on cytokine profiles and the regulation of
immunologically relevant cell markers. The participation
of APC in the immune response is crucial and the
examination of cytokine responses may provide informa-
tion valuable to understanding the polarisation or the
characteristics of the adaptive immune response. Also,
presentation of antigens by APC requires an adequate
expression of some molecules, of which MHC-I and
MHC-II will be directly involved in presentation to CD4
and CD8 T cells. However, other molecules such as
CD80/86 will be involved in such a presentation. The
coincident expression of the CD80/86 co-stimulatory
molecule will be crucial for determining the outcome of
the antigen presentation-recognition by Th cells. Other
molecules that were examined in this study, such as
CD163 are in turn directly implied in the process of
entry and replication of PRRSV. It is thought that
CD163 is responsible for the uncoating of PRRSV once
inside the cell. Other cell surface markers such as CD14
or SwC3, SwC9 may indicate different states of matura-
tion of the dendritic cells.
The data presented in this work show that different
PRRSV isolates are able to induce different patterns of
cytokines and may modulate with different intensity the
expression of immunologically relevant molecules.
Materials and methods
Viruses
Thirty-nine PRRSV strains were used in this study
(Table 1). This set of strains included genotype-I
(European) isolates from 1991 to 2006 of which some
were retrieved from a viral collection (n = 15) and
others were freshly isolated from frozen (-80 C) serum
(n = 9) or lung tissue (n = 15) that have yielded positive
results for PRRSV by RT-PCR. Freshly isolated viruses
were from Spain and Portugal and archive viruses were
from different countries of Western Europe. No epide-
miological relationship was known to exist between the
different isolates. Isolation was done in porcine alveolar
macrophages (PAM) obtained from two healthy pigs
free from all major diseases including PRRSV, pseudora-
bies virus and classical swine fever virus. Additionally,
all PAM batches were tested for porcine circovirus
type 2 (PCV2), hepatitis E virus and torque-tenovirus
(TTV) according to previously described PCR protocols
[14-16]. Viral stocks were also tested for mycoplasma by
PCR. Viral stocks were produced from passages n = 2,
n = 3 or n = 4 in PAM and, for each strain, batches of
virus were larger enough to assure that the same batch
c o u l db eu s e di na l lt h ee x p e r i m e n t sp e r f o r m e dw i t h
that isolate, avoiding thus the use of different viral
batches of the same strain for different experiments or
replicas. Viral titrations were performed by inoculation
of serial dilutions of viral stocks in PAM and readings
were done by means of the immunoperoxidase mono-
layer assay using monoclonal antibodies for ORF5 (clon
3AH9, Ingenasa, Madrid, Spain) and ORF7 (clon 1CH5,
Ingenasa, Madrid, Spain) using a method reported
before with minor modifications [17].
In order to examine the need for virus viability for the
induction of cytokines, thre eo ft h ei s o l a t e sw e r er e -
tested in parallel before and after inactivation by heat
(60°C, 60 min). Complete inactivation was verified by
inoculation of the heat-treated viral suspensions in
PAM, which were examined at 72 h post-inoculation for
the cytopathic effect and presence of PRRSV by IPMA.
Untreated viable virus was used to assess the adequate-
ness of the PAM batches for titrations.
Isolation of bone marrow hematopoietic cells (BMHC) and
differentiation of bone marrow-derived dendritic cells
Bone marrow hematopoietic cells were isolated, using a
method previously described by Summerfield et al. [18]
with minor modifications, from femora and humera of
two PRRSV seronegative 6-week-old piglets obtained
f r o mah e r dh i s t o r i c a l l yf r e eo fP R R S V .T h ec e l l s
obtained were frozen until needed. Bone marrow-derived
dendritic cells were deriv e db yu s i n gt h ep r o t o c o l
reported by Carrasco et al. [19]; namely, BMHC were cul-
tured (37°C; 5% CO2) in Petri dishes (1 × 10
6 cells/mL in
10 mL of culture medium) with derivation medium
(DM), namely RPMI 1640 medium supplemented with
10% fetal calf serum (FCS) (Invitrogen, Prat del Llobre-
gat, Spain), 40 mM/mL L-glutamine (Invitrogen), 100 u/
mL polimixine (Invitrogen), 50000 IU penicillin (Invitro-
gen), 50 mg/mL gentamicin (Sigma, Madrid, Spain),
100 ng/mL recombinant porcine granulocyte-monocyte
colony stimulating factor (rpGM-CSF) (R&D systems,
Madrid, Spain). On the third day of culture, the
exhausted culture medium was replaced with 10 mL of
fresh DM and, at day 6, half of the culture medium was
replaced by fresh DM. Finally, at day 8 of culture, BMDC
were collected by centrifugation and used in the assays.
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cells (PBMC), SwC3
+ blood mononuclear cells and alveolar
macrophages
Peripheral blood mononuclear cells and PAM were
obtained from healthy pigs free from all major diseases
as mentioned above. Peripheral blood mononuclear cells
were separated from whole blood by density-gradient
centrifugation with Histopaque 1.077 (Sigma). SwC3
+
(CD172a
+) cells were purified from PBMC by positive
selection using MACS Microbeads (Miltenyi Biotech SL,
Pozuelo de Alcorcon, Spain). Briefly, the cells were incu-
bated with mouse anti porcine CD172a-FITC (Serotec,
Madrid, Spain) on ice for 30 min. After incubation,
PBMC were washed and SwC3
+ cells were coupled
(15 min on ice) with anti-FITC magnetic particles (Mil-
tenyi Biotec). Thereafter, PBMC were washed again and
resuspended in MACS buffer (PBS plus foetal calf
serum) and labelled cells were retrieved using LS selec-
tion columns (Miltenyi Biotec) according to the manu-
facturer’s instructions. The purity of the cellular
suspension was examined by flow cytometry analysis
before further characterisation. The cell suspension
obtained always had a richness of SwC3
+ ≥ 92%.
Porcine alveolar macrophages were obtained by
bronchoalveolar lavage of the lungs of piglets. After
humane euthanasia, the lungs were removed aseptically
and washed by infusion of PBS (Sigma) supplemented
with 2% gentamicin through the trachea. The retrieved
cell suspension was centrifuged (10 min at 450 g),
washed and then the cells were frozen in liquid nitrogen
until needed. Porcine alveolar macrophages were pro-
duced by adhesion to plastic of the retrieved cells. Paral-
lel cultures of PAM were always examined for PRRSV
and PCV2 by PCR as described above.
All these types of cells were cultured using RPMI 1640
medium supplemented with 10% FCS (Invitrogen,
Madrid, Spain), 1 mM non-essential amino acids
(Invitrogen), 1 mM sodium pyruvate (Invitrogen), 5 mM
2-mercaptoethanol (Sigma), 50000 IU penicillin (Invitro-
gen), 50 mg streptomycin (Invitrogen) and 50 mg genta-
micin (Sigma). Trypan blue was used to assess viability.
Cytokine profiles induced by different PRRSV strains
Four different types of cells were used: PBMC, PAM, per-
ipheral blood SwC3
+ and BMDC. All cell types were cul-
tured in supplemented RPMI as stated above. Peripheral
Table 1 Description of the 39 European PRRSV isolates used in the present study
Isolate Titre log (TCID50/mL)* Year Tissue Isolate Titre log (TCID50/mL)* Year Tissue
2652 4.4 2005 Serum 2996 5.4 2005 Lung
2654 4.9 2005 Serum 2998 4.8 2003 Lung
2655 4.9 2005 Serum 3003 5.0 1994 Serum
2658 4.6 2005 Serum 3004 4.8 1994 Serum
2744 6.2 1991 Serum 3005 5.1 1994 Serum
2751 5.4 2005 Serum 3009 4.9 2005 Lung
2788 6.0 2006 Serum 3012 5.5 1997 Serum
2797 5.2 1991 Serum 3013 4.9 2004 Lung
2804 5.7 1992 Serum 3016 6.4 1991 Serum
2805 6.8 1992 Serum 3249 4.8 1991 Serum
2810 4.6 1992 Serum 3256 4.8 2005 Lung
2812 4.7 1992 Serum 3262 5.1 2005 Lung
2894 5.8 1991 Serum 3266 7.0 1991 Serum
2896 5.7 1991 Serum 3267 6.9 2006 Serum
2982 4.7 2005 lung
2983 4.7 2005 Serum
2986 4.8 2005 Lung
2987 4.9 2005 Lung
2988 4.9 2003 Lung
2990 5.5 2005 Lung
2991 5.1 2006 Lung
2992 4.9 2006 Lung
2993 4.9 2006 Lung
2994 5.0 2006 Lung
2995 5.1 2004 Lung
*Maximum yield of viable virus obtained in cell culture supernatants (72 h) for a given strain after inoculation of 1 × 10
7 porcine alveolar macrophages (10 mL
cell culture medium) with every strain at any multiplicity of infection.
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10
6 cells/well in 1 mL of medium; PAM and SwC3
+ cells
were cultured at 5 × 10
5 cells/well in 0.5 mL of medium
and BMDC at 1 × 10
6 cells in 1 mL of culture medium. In
preliminary experiments, the cells were stimulated
with PRRSV at 0.1, 0.05 and 0.01 multiplicity of infection
(m.o.i.) for 24 h. Since the profiles were not different in
terms of positive/negative induction of a given cytokine, a
0.01 m.o.i. was chosen for final experiments using all 39
strains. All strains were examined three times (separate
days), in triplicate cultures each time. For a given series of
tests, all strains were tested in cells coming from the same
animals. As a negative control, supernatants from mock-
infected PAM were included. As positive controls, PHA
(10 μg/mL) was used for PBMC and, LPS (10 μg/mL) and,
gastroenteritis transmissible virus (m.o.i 0.01) for the other
types of cells. Each time, cell culture supernatants of the
three replicas were collected and mixed and the resulting
mixtures were examined by ELISA to determine the con-
centrations of IFN-a, IL-10 and TNF-a (this cytokine was
only examined in BMDC and SwC3
+ cells). Also, for
PAM, IL-1 and IL-8 were examined by means of commer-
cial ELISA (R&D Systems). IFN-a capture ELISA was per-
formed as reported previously [20] using K9 and F17
monoclonal antibodies. F17 was biotinylated (Phase Bioti-
nylation Kit, PIERCE, Madrid, Spain). IFN-a recombinant
protein (PBL Biomedical lab, Piscataway, New Jersey) was
used as a standard. IL-10 capture ELISA was performed
using commercial pairs of mAbs (swine IL-10, Biosource,
Madrid, Spain) [2]. TNF-a capture ELISA was performed
according to the manufacturer’s instructions (Porcine
TNF-a R&D systems). Cut-off of each ELISA was calcu-
lated as the mean optical density of negative controls plus
three standard deviations. The values for the cytokine con-
centration in cell culture supernatants were calculated as a
corrected concentration resulting from the subtraction of
cytokine levels in mock-stimulated cultures from the
values obtained for virus-stimulated cultures (concentra-
tionPRRSV-concentration mock).
Phenotyping of bone marrow-derived dendritic cells
before and after virus infection
Phenotypic characterisation of BMDC was done by
means of flow cytometry at days 0 and +8 of the deriva-
tion process. Bone marrow-derived dendritic cells were
further cultivated for 48 h more in DM without rpGM-
CSF in the presence or absence (supernatants of mock-
infected PAM) of different strains of PRRSV at 0.01 m.o.i
and examined again. All strains were examined three
times (separate days). The relative proportions of cells
expressing SLA-I, SLA-II (DR), CD80/86, CD163, SwC3,
SwC9, CD14 and CD16 were determined using mAbs
4B7, 2E9/13, mouse anti-porcine CD80 (Abyntek, Derio,
Spain), 2A10/11, BL1H7, mouse anti-porcine SwC9-FITC
(Serotec, Madrid, Spain), mouse anti-porcine CD14-FITC
(Serotec), mouse anti-porcine CD16-FITC (Serotec). To
further assess the effects of PRRSV infection, a double
staining was performed for the SLA-II/CD80/86 and SLA-
II/CD163 pairs. Four isolates were used for phenotype
characterisation: isolate 3267 (IL-10
-/TNF-a
-), 3262 (IL-10
+/TNF-a
+), 3249 (IL-10
-/TNF-a
+) and 2988 (IL-10
+/TNF-a
-). In addition, cell culture supernatants
(48 hours) of BMDC inoculated with PRRSV at 0.01 m.o.i
were titrated in PAM as described above. In a second part
of this experiment, the cells were incubated for 48 h with
PRRSV isolates selected on the basis of their ability to
induce cytokine release in BMDC: 3267 (IL-10
-/TNF-a
-),
3262 (IL-10
+/TNF-a
+), 3249 (IL-10
-/TNF-a
+) and 2988
(IL-10
+/TNF-a
-) and treated with a neutralising anti IL-10
antibody (0.15 μg/mL). After incubation, the cells were
re-examined for changes in the phenotype.
Statistical analysis
Statistical analyses were done using Statsdirect v.2.7.5.
The comparison of the amounts of cytokines in different
cell types was done using the Mann-Whitney test. The
comparison of viral titres and cytokine levels was done
by linear regression. The comparison of the results
obtained in flow cytometry experiments (average and
standard deviations) was performed using the Kruskal-
Wallis test with multiple comparisons (Conover-Inman
method). Statistical significance was set at p < 0.05.
Results
Cytokine profiles induced by different PRRSV strains
Examination of cell culture supernatants of PBMC
yielded negative results for IFN-a for all PRRSV isolates.
For IL-10, 9/39 strains induced the release of this cyto-
kine (mean concentration 53 pg/mL; range 45-81 pg/mL)
of which one was also positive for TNF-a. Eleven addi-
tional isolates also induced TNF-a in PBMC but not
IL-10. Regarding PAM, all isolates were negative for
IFN-a and 12 were positive for IL-10 but producing low
levels (50 pg/mL; range 35-65 pg/mL) after correction.
Also, all examined isolates induced high levels of IL-8
and IL-1 in PAM (on average > 8000 pg/mL for IL-8 and
326 ± 195 pg/mL for IL-1). For BMDC, seven strains
were able to induce IL-10 release and 24 strains induced
TNF-a;f i v es t r a i n sw e r eI L - 1 0
+/TNF-a
+ positive and
13 were double negative (Table 2). In SwC3
+ cells, 21
strains induced IL-10 (comprising all but one of the
BMDC IL-10 inducing strains) and 30 strains induced
TNF-a (including all the TNF-a inducing strains for
BMDC). Regarding IFN-a, all strains were negative but
two that yielded borderline (close to cut-off) results in
the ELISA. In any case, BMDC and SwC3
+ cells were the
more sensitive methods for the detection of these cyto-
kine responses. Heat inactivation of the virus eliminated
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TNF-a but did not enhance IFN-a release. No differences
were found regarding the amount of a given cytokine
induced by strains in the same cell type; however, SwC3
+
were higher producers of TNF-a than other cell types,
particularly than BMDC (p < 0.05). Thus, when consider-
ing all strains producing TNF-a regardless of the IL-10
profile, average concentration of TNF-a in cell culture
supernatants of SwC3
+ cells was 1027 ± 775 pg/mL versus
575 ± 400 pg/mL for BMDC (p = 0.046). This difference
was not seen for IL-10. No correlation was observed
between the viral titer and the levels of a given cytokine.
Phenotyping of BMDC before and after virus infection
Freshly derived BMDC show the expected phenotype
from the review in the literature and thus, this was a het-
erogenous population where about 30% of the cells
expressed high levels of SLA-II (DR); 14% were CD163
+;
31% were SwC3
+, 52% were CD14
+ and 55% were CD16
+
(figures not shown). These cells were inoculated with dif-
ferent PRRSV strains selected considering the different
cytokine-inducing phenotypes in BMDC or they were
mock-inoculated with cell culture supernatants of PAM.
After 48 h of incubation, mock-inoculated BMDC
showed signs of maturation as evidenced by the increased
proportion of cells expressing SLA-II, CD80/86, SwC3
and CD163 (data not shown).
Examination of BMDC 48 h after inoculation with the
virus showed that strains with different cytokine-
inducing properties regulated several cell markers differ-
e n t l y( F i g u r e1a n dT a b l e3 ) .F o rS L AI ,c o m p a r e dt o
mock-inoculated cells, strains 3267, 3249 and 3262 pro-
duced a decrease in the expression of that molecule
while no changes were observed for strain 2988. For
SLA-II, all strains but 3249 produced significant
increases in expression (p < 0.03) compared to unin-
fected cells. For CD80/86, the behaviour of BMDC after
infection differed depending on the strains. Interestingly,
the double negative cytokine-inducing strain (3267) was
the one that produced the highest increase in the
expression of CD80/86 while the double positive strain
(3262) produced a decrease in CD80/86 compared with
the uninfected control (p = 0.01). For CD14, compared
to the uninfected cells, the expression increased for
strain 3262 (double positive cytokine-inducing strain),
decreased for strain 3267 (double negative cytokine-
inducing strain) and no changes were observed for
strain 3249 and 2988. Regarding CD163, expression
decreased only in the double negative strain (3267).
When strain 3249 was used for stimulation, CD163
showed a trend for an increase although the p-value was
not strictly significant (p =0 . 0 9 ) .C o m p a r e dt ou n i n -
fected cells, CD16 expression was always reduced upon
PRRSV inoculation (p = 0.02) except for isolate 2988
a n dn od i f f e r e n c e sw e r ef o u n df o rS w C 9a n dS W C 3
expression. To further gain insight into these changes,
SLA-II, CD80/86, and CD163 were examined in double
staining experiments (Figure 2). The results show that
strain 3262 (IL-10
+/TNF-a
+)p r o m o t e da ni n c r e a s ei n
the expression of single SLA-II
+ (76% in inoculated cells
versus 63% in mock-inoculated cells) simultaneously
with a reduction of CD80/86 expression. It is worthy to
note the decrease in the double positive subset percen-
tage (7% in mock-infected cells; 3% in 3262-inoculated
cells). In contrast, cells infected with 3267 (IL-10
-/TNF-
a
-) exhibited an increase (75.7%) in the total proportion
of SLA-II
+ single expressing cells but the numbers of
SLA-II
-/CD80/86
+ cells increased (from 8.5% in unin-
fected cells to 13.0% in 3267 infected cultures). For
CD163, IL-10 inducing strains were able to keep the
proportions of double positive SLAII/CD163 cells com-
pared to mock-inoculated culture cells while infection
with a IL-10
-/TNF
- strain (3267) produced a clear
decline of double positive SLAII/CD163 cells.
Titration in PAM of the cell culture supernatants pro-
duced in BMDC yielded titers of 10
6.5,1 0
5.5 and 10
5.0
TCID50/mL respectively for strains 3267, 3249 and 3262.
These same strains yielded titers of 10
6.9,1 0
4.8 and 10
5.1
TCID50/mL when directly cultured in PAM under the
same conditions, indicating no substantial differences
between PAM and BMDC for supporting viral replication.
Effects of IL-10 blocking
As Figure 3 illustrates, blocking of IL-10 resulted in
upregulation of the expression of SLA-I, downregulated
CD14 and had no effect (strain 2988 IL-10
+/TNF-a
-)o r
downregulated (strain 3262 IL-10
+/TNF-a
+) CD80/86
and SLA-II.
Table 2 Distribution of 39 genotype-I PRRSV isolates according to their cytokine profiles
BMDC SwC3
+
IL-10 pg/mL* NA NA 183 ± 137 (280-86) 410 ± 98 (522-297) NA NA 323 ± 259
(752-119)
501 ± 363
(1352-77)
TNF-a Pg/mL* NA 502 ± 293
(1070-91)
NA 432 ± 300
(941-201)
NA 879 ± 715
(2,039-103)
NA 1321 ± 939
(2847-229)
Total strains 13 19 2 5 5 13 4 17
*Cytokine-inducing profiles for IL-10 and TNF-a were obtained using bone marrow-derived dendritic cells and sorted SwC3
+ peripheral blood mononuclear cells
inoculated at a multiplicity of infection of 0.01. Values in the table show the average, standard deviation and range (pg/mL) of the concentrations in cell culture
supernatants obtained for a set of strains inducing a given cytokine.
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Figure 1 Single colour flow cytometry analysis of changes in several immunologically relevant cell surface molecules of bone marrow-
derived dendritic cells after 48 h of incubation with different PRRSV strains at a multiplicity of infection of 0.01 (as determined by
titration in porcine alveolar macrophages). Grey histograms show cells stained with an irrelevant isotype-matched antibody and a secondary
FITC or phycoerithrin conjugated antibody. Blue histograms show uninfected cells and red line histograms correspond to PRRSV-infected cells.
Averages and variation coefficients are included. Grey values show the uninfected cell parameters and black values correspond to PRRSV-infected
cells. A) SLA-I, SLA-II, CD80/86, CD14; B) SwC3, SwC9, CD163, CD16.
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Knowledge of interactions between PRRSV and APC is
crucial to understand the unique features of the immu-
nity and pathogenesis of PRRS. PAM are considered to
be the main targets for PRRSV [17] although several
reports [11-13,21-23] have shown that different DC may
support replication of the virus, suffer a regulation of
immunologically relevant cell surface proteins as well as
produce cytokines upon infection with PRRSV. An accu-
rate review of the scientific literature, however, reveals
that every study intended to clarify the effects of the
abovementioned interactions produced different results.
Some papers indicated that PRRSV downregulates SLA-I
and/or SLA-II while some others did not [11,12,21-23]
or, for example, CD80/86 have been shown to be up
and downregulated by PRRSV [11,12,21]. Similarly,
some papers showed that IL-10 and TNF-a are cyto-
kines produced by DC or PAM upon PRRSV infection,
while some other papers reported the inability to detect
these cytokines [9,11,12,21,23-26]. To say the least, this
is an unusual picture for an animal virus. Thus, since
cytokines are crucial elements in the regulation of the
immune system and different works reported different
findings regarding the ability of PRRSV in inducing
cytokine responses, the present work started by asses-
sing whether or not that different ability to induce cyto-
kine release was a spurious fact or a characteristic of a
given isolate. For this, a large set (n = 39) of PRRSV
strains was isolated or retrieved from a collection and
examined. To our knowledge no other study published
before examined such a number of PRRSV isolates.
To categorise the isolates regarding their capabilities for
inducing cytokine responses, four different cell systems
w e r eu s e d :P A M ,P B M C ,B M D Ca n dS w C 3
+ peripheral
blood cells and three cytokines considered crucial in the
development of the immune response were examined:
IFN-a,I L - 1 0a n dT N F - a. Our study primarily revealed
that every cell type has a different sensitivity in terms of
the cytokine response against PRRSV and, as expected, the
more specialised professional APC, BMDC and SwC3
+
cells showed the greater ability to produce cytokines and
SwC3
+ cells were particularly highly sensitive. This differ-
ence between cell models indicates that responses of APC
to PRRSV are also subjected to the idiosyncrasy of a parti-
cular cell type and emphasises the need to consider the
system in which the results are obtained to have a correct
interpretation of these cytokine readouts. Other authors
[22] also reported that different types of DC have different
susceptibilities to PRRSV and that they react differently to
PRRSV infection. Therefore, the complexity of the in vivo
response to the virus would be expected to reflect the het-
erogeneity of responses as well. In any case, examination
of cell culture supernatants of BMDC or SwC3
+ cells
showed that IFN-a was not released upon PRRSV infec-
tion in accordance with previous reports using DC or
PAM [7,22]. Interestingly, all four possible cytokine-
inducing phenotypes for IL-10 and TNF-a were detected
(from negative-negative to positive-positive) and, in most
cases, differences between BMDC and SwC3
+ cells were in
the sense of a greater sensitivity of SwC3
+ cells. Both cyto-
kines, IL-10 and TNF-a, were produced as a result of the
interaction with viable virus since inactivated virus did not
induce them. Although the study of the mechanisms of
regulation of cytokines was out of the scope of the present
work, non structural PRRSV proteins could also be
involved in this process. A recent paper [27] suggested
that variations in TNF-a induction may be the result of
variations in ORF-1a. These results might explain by
themselves many of the discrepancies reported in the lit-
erature mentioned at the beginning of the present
discussion.
The next step was to examine the effect of PRRSV
infection in BMDC upon immunologically relevant cell
surface molecules of BMDC. In general, the picture
resulting from the flow cytometry observations did not
support clear correlation b e t w e e nag i v e nc y t o k i n e
Table 3 Immunologically cell surface molecules in bone marrow-derived dendritic cells
Porcine reproductive and respiratory virus isolates used for stimulation of bone marrow-derived dendritic cells
#
Molecule Uninfected 3267 3249 2988 3262 p-value
SLA-I 98.2 ± 0.9
a 93.9 ± 1.2
b 93.5 ± 2.4
b 98.3 ± 1.3
a 94.0 ± 1.6
b P = 0.04
SLA-II 69.9 ± 3.5
a 81.8 ± 3.4
b 74.4 ± 1.7
a 79.4 ± 4.0
b 79.7 ± 3.8
b P = 0.03
CD80/86 15.2 ± 1.2
a 29.4 ± 5.7
b 13.4 ± 2.8
a 15.9 ± 1.3
a 10 ± 1.7
c P = 0.01
CD14 85.4 ± 2.2
a 81.4 ± 1.3
b 84.5 ± 1.3
a 86.4 ± 1.3
a 93.8 ± 0.3
c P = 0.03
SWC3 85.5 ± 5.8 75.5 ± 17.3 87.5 ± 9.7 81.4 ± 7.8 83.9 ± 2.7 P = 0.78
SWC9 52.2 ± 27.4 45.5 ± 5.6 42.3 ± 5.6 30.6 ± 1.6 33.6 ± 6.6 P = 0.24
CD163 19.7 ± 2.1
a 4.9 ± 3.5
b 24.6 ± 7.0
a* 18.1 ± 4.7
a 18.2 ± 1.5
a P = 0.03
CD16 88.8 ± 7.6
a 65.8 ± 3.7
b* 50.8 ± 15.6
c 83.0 ± 2.4
a 70.2 ± 0.7
b P = 0.02
#Average expression (three replicas) of some immunologically relevant cell surface molecules in bone marrow-derived dendritic cells. Each cell shows average
percentage of cells expressing a given molecule and the standard deviation of the three observations. The comparison of the results was done using the Kruskal-
Wallis test (p-value shown in the table) with multiple comparisons. Different superscript letters indicate statistically different (p < 0.05) percentages.
*p = 0.09.
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Page 7 of 10production pattern and the modification of different
immunologically relevant cell surface markers. However
strain 3267, which was unable to induce IFN-a,T N F - a
or IL-10 release in any of the cell systems examined,
produced extreme changes compared to the cytokine-
inducing strains. Thus, strain 3267 induced the highest
percentage of expression of SLA-II and CD80/86 and
the lowest for CD163 and CD14. However, this
increased expression of SLA-II and CD80/86 was not a
co-expression in the same cells. Therefore, although
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Figure 2 Dual colour flow cytometry analysis of bone marrow-derived dendritic cells at 48 h post inoculation with different PRRSV
isolates at 0.01 m.o.i.: A) SLA-II and CD80/86; B) SLA-II and CD163.
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Page 8 of 10increased, this could not lead necessarily to a more
effective immune response. In fact, the lack of cytokine
release upon a viral infection suggests a deep alteration
of the expected response.
On the other side, the double positive strain (3262)
induced the lowest percentage expression of CD80/86,
the highest CD14 expression and a decreased percentage
of cells expressed SLA-I compared to uninfected con-
trols. To determine the role of IL-10, a blocking experi-
ment was performed. That blocking of IL-10 restored
SLA-I expression, partly restored CD80/86 expression,
and reduced the expression of CD14; indicating that, at
least, IL-10 was partially involved in the down-
regulation of those molecules although, more than one
regulation mechanism probably exists.
For CD163, the present results do not give a clear
image of what happens with this molecule. Although
some authors have described the ability of some strains
to induce the expression of the viral co-receptor CD163
[28,29] which is known to be up-regulated by IL-10
[30], with our data, no correlation was found between
the ability of the strain to induce IL-10 and the capabil-
ity to enhance the expression of CD163.
In summary, the present paper shows that different
PRRSV isolates may induce different patterns of cytokine
release in APC, and may regulate differently the expres-
sion of immunologically relevant molecules. Also, it
shows that IL-10 seems to play an important role in
SLA-I, CD14 and probably CD80/86 but it is evident that
this cytokine is not the only element in that regulation
and, as some reports indicate [31,32] non-structural pro-
teins seem to play an important role in the regulation of
the innate responses against PRRSV. From a practical
point of view, the present results also suggest that immu-
nological studies of PRRSV cannot be performed with a
single PRRSV strain if a global vision is desired or that
genetic variability of PRRSV has to be taken into account
when using clones or in vitro models.
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Figure 3 Effect of IL-10 blocking in BDMC infected with two
different PRRSV strains upon expression of SLA-I, SLA-II, CD80/
86 and CD14. Black solid lines represent the results obtained
incubating BMDC with PRRSV in plain culture medium and red
dotted lines represent the results obtained after IL-10 blocking.
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